The so far known CCM patients with a loss-of-function SMARCE1 mutation have no clinical signs of Coffin-Siris syndrome, and screening for developmental delay or dysmorphisms is therefore not necessary. The gene discussed is SMARCE1; the disease is Global developmental delay.